Evidence records
A28 Therapeutics — Wikidata Q139829650 evidence
A28 Therapeutics — Wikidata Q139829650; Clinical-stage biopharmaceutical company developing targeted oncolytic peptides (TOPs) for treating cancer.; source revision 2493740168, modified 2026-05-18T11:24:07Z.
Evidence records
The details below reflect the retained source records. Follow the references to check their context; missing information is not filled in.
Source description
Clinical-stage biopharmaceutical company developing targeted oncolytic peptides (TOPs) for treating cancer.
Sourcewww.wikidata.orgSource-listed website
www.a28therapeutics.com — https://www.a28therapeutics.com
Sourcewww.wikidata.orgWikidata item
Wikidata Q139829650
Sourcewww.wikidata.orgSource revision
2493740168, modified 2026-05-18T11:24:07Z
Sourcewww.wikidata.org
Continue exploring
About these subjects
Related source records
Data & record details
Download the same cited information as JSON. The revision identifiers below distinguish changes to the facts from changes to the subjects included.
Download this recordapplication/json
- Surface ID
- urn:readyscan:corpus:evidence:a28-therapeutics-q139829650
- Material fingerprint
- fnv1a64:179267eb6f1bcb5f
- Membership fingerprint
- fnv1a64:05bfd37c46f18bdf
- Published
- 2026-07-29
- Modified
- 2026-07-29